MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2026 International Congress

    A Novel Bedside Clinical Test (“Vibration” Sign) Improves Diagnostic Differentiation of Functional Movement Disorders: A Prospective Pilot Study

    D. Garg, F. Mustafa, A. Agarwal, V. Patil, A. Srivastava (New Delhi, India)

    Objective: To assess the diagnostic accuracy, inter-rater reliability, and clinical feasibility of the “vibration” sign for identifying Functional Movement Disorders (FMD). Background: FMD account for…
  • 2026 International Congress

    Heterogeneous Responsiveness to Combined Motor–Cognitive Exercise in Parkinson’s Disease: A Latent Class Analysis

    J. Hwang, C. Youm, H. Park, M. Kim, B. Kim, S. Cheon (busan, Republic of Korea)

    Objective: To evaluate the effects of a combined motor–cognitive exercise intervention in individuals with Parkinson’s disease (PD) and to explore latent response subgroups to identify…
  • 2026 International Congress

    Hip and Elbow Joint Angle Characteristics of Patients with Parkinson’s Disease

    D. Rasmiyani, A. Husni, E. Pasmanasari, A. Wati (Semarang, Indonesia)

    Objective: This study aimed to examine the hip and elbow joint angles during walking in Parkinson’s disease patients compared to healthy individuals. Background: Parkinson’s disease…
  • 2026 International Congress

    Pulsatile Striatal Dopamine Dynamics Drive Levodopa Induced Dyskinesia In Advanced Parkinson Disease

    L. Su, A. Li, Z. Li, Y. Guo (Shanghai, China)

    Objective: To determine how pathological striatal dopamine fluctuations relate to dyskinesia and motor output in levodopa induced dyskinesia. Background: Levodopa induced dyskinesia is a major…
  • 2026 International Congress

    Differential Effect of MAO-B Inhibitors in GBA1 Carriers with Parkinson’s Disease Women vs Men

    H. Saragani, R. Henner, M. Cohen, S. Vilk, A. Zimran, I. Harari, R. Eichel, G. Yahalom, M. Cohen (Jerusalem, Israel)

    Objective: To investigate the longitudinal impact of MAOIs on motor progression among Parkinson's disease (PD) patients carrying GBA1 mutations, with an emphasis on sex-stratified clinical…
  • 2026 International Congress

    Determinants of depression severity in patients of Spinocerebellar ataxia 12

    J. Bilga, N. Sawal, A. Prasad (Chandigarh, India)

    Objective: To evaluate clinical and radiological co-relates of depression in Spinocerebellar ataxia -12 Background: Spinocerebellar ataxia type 12 (SCA12), caused by a CAG repeat expansion…
  • 2026 International Congress

    Outcomes from Unilateral MR-Guided Focused Ultrasound Pallidothalamic Tractotomy for Advanced Parkinson’s Disease

    H. Sarva, K. Gant, C. Modak, C. Ferrer, A. Sokolov, A. Grinspan (New York, USA)

    Objective: To evaluate the safety, efficacy, and patient-reported outcomes of unilateral MRgFUS pallidothalamic tractotomy (PTT) for the treatment of aPD. Background: In July 2025, the…
  • 2026 International Congress

    Diagnostic Delay in Multiple System Atrophy: Sociodemographic and Clinical Predictors in a Single-Center Cohort

    T. Kaneko, E. Krening, M. Bruno (Honolulu, USA)

    Objective: To evaluate sociodemographic and clinical predictors of diagnostic delay in multiple system atrophy (MSA) at a single tertiary referral center. Background: MSA is a…
  • 2026 International Congress

    The Effects of War on Patients with Parkinson’s Disease

    F. Hojjatipour, M. Salari, M. Etemadifar, K. Rezaei (Tehran, Islamic Republic of Iran)

    Objective: In this study, we aim to evaluate whether patients perceived stress more than healthy controls and what symptoms were correlated with this stress by…
  • 2026 International Congress

    Genetic determinants of cognitive performance in Parkinson’s disease: impact of distal regulatory variation at the SNCA locus in the gp2 cohort

    D. Náfate Wences, A. Cervantes Arriaga, M. Rodríguez Violante, MT. Periñán Tocino, GP2. Genetics Program (Mexico City, Mexico)

    Objective: This study evaluates the association between a distal regulatory haplotype at the SNCA locus and cognitive performance, measured by the Montreal Cognitive Assessment (MoCA),…
  • « Previous Page
  • 1
  • …
  • 137
  • 138
  • 139
  • 140
  • 141
  • …
  • 208
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley